Nivolumab-ipilimumab combination granted priority review by FDA
The Food and Drug Adminitration in the US has granted [...]
The evolving management of advanced renal cell carcinoma
This article, published in UroToday this week, is a nice summary [...]
Neoadjuvant and adjuvant therapy for renal cell carcinoma: critique, current trials and future directions
The following articles discuss the use of neoadjuvant therapy (drug [...]
The impact of immunotherapy on the treatment of kidney cancer
Professor Thomas Powles, Barts Cancer Institute, London discusses the impact [...]
First-line treatment for metastatic kidney cancer – an interview with Dr Eric Jonasch
The following is an interview with Dr Eric Jonasch, Professor [...]
Novel immunotherapy combinations show promise for renal cell carcinoma
The following is an interview with Dr Matthew Zibelman, assistant professor [...]
Promising new front-line treatments for advanced kidney cancer
In an interview with OncLive during the 2017 State of the Science [...]
European Society of Medical Oncology (ESMO) highlights from the IKCC
The International Kidney Cancer Coalition (IKCC) had a booth at [...]
Kidney cancer highlights from the European Society of Medical Oncology
The following is an interview with Dr Toni K. Choueiri, medical oncologist at [...]
Bristol-Myers Squibb stops combination immunotherapy clinical trial due to positive interim results
Bristol-Myers Squibb (BMS) has reported positive phase 3 results for its clinical [...]
